FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Astrazeneca Pharma India LtdIndustry : Pharmaceuticals - Multinational
BSE Code:506820 NSE Symbol: ASTRAZEN P/E (TTM) :128.8
ISIN Demat:INE203A01020 Div & Yield %:0 EPS (TTM) :70.02
Book Value (RS) :308.14 Market Cap (Rs Cr.):22545.75 Face Value (RS) :2
    Change Company 
Particulars Quarter Ended
(Mar 2025)		 Quarter Ended
(Mar 2024)		 Quarter Ended
(% Var)
Sales 480.48 383.20 25.39
Other Income 16.15 8.66 86.49
PBIDT 96.84 58.05 66.82
Interest 0.68 -0.07 0.00
PBDT 96.16 58.12 65.45
Depreciation 17.69 3.76 370.48
PBT 78.47 54.36 44.35
Tax 22.92 15.52 47.68
Deferred Tax -2.70 -0.64 0.00
PAT 58.25 39.48 47.54

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)